The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that the Board of Directors has authorized the repurchase of $60 million of the Company's common stock through February 8, 2009 under its ongoing share repurchase program. Any remaining balance of the previously authorized program will expire on February 17, 2007. Under share repurchase programs since November 2000, Perrigo has repurchased 9.4 million shares at a cost of approximately $118 million. As of January 29, 2007, Perrigo had 92,589,609 common shares outstanding.
The Company also announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on March 20, 2007 to shareholders of record on February 23, 2007.
The Perrigo Company is a leading global healthcare supplier and the world's largest manufacturer of over-the-counter (OTC) pharmaceutical and nutritional products for the store brand market. Store brand products are sold by food, drug, mass merchandise, dollar store and club store retailers under their own labels. The Company also develops, manufactures and markets prescription generic drugs, active pharmaceutical ingredients and consumer products, and operates manufacturing facilities in the United States, Israel, the United Kingdom, Mexico, Germany and China. Visit Perrigo on the Internet (http://www.perrigo.com/).
First Call Analyst:
FCMN Contact: pblain@perrigo.com
SOURCE: Perrigo Company
CONTACT: Arthur J. Shannon, Vice President, Investor Relations and
Communication, +1-269-686-1709, ajshannon@perrigo.com, or Ernest J. Schenk,
Manager, Investor Relations and Communication, +1-269-673-9212,
eschenk@perrigo.com, both of Perrigo Company
Web site: http://www.perrigo.com/